Smad7 inhibits AngII-mediated hypertensive nephropathy in a mouse model of hypertension

Clinical Science

Volumn 127, Issue 3, 2014, Pages 195-208

  Liu, Guan Xian ^a   Li, You Qi ^a   Huang, Xiao R ^b   Wei, Li Hua ^b   Zhang, Yang ^b   Feng, Min ^b   Meng, Xiao Ming ^b   Chen, Hai Yong ^b   Shi, Yong Jun ^a   Lan, Hui Y ^b  

^a Department of Nephrology   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hypertensive nephropathy; MiR 29; Nuclear factor B (NF B); Smad3; Smad7; Sp1

Indexed keywords

ANGIOTENSIN II; CREATININE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 29B; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN PROTEIN LIGASE E3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED CLINICAL TRIAL (TOPIC); CREATININE BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY INJURY; MOUSE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; UPREGULATION;

ANGIOTENSIN II; ANIMALS; DISEASE MODELS, ANIMAL; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HYPERTENSION, RENAL; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; KIDNEY; KIDNEY DISEASES; MACROPHAGES; MALE; MICE; MICE, INBRED STRAINS; NEPHRITIS; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD7 PROTEIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84898772136     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130706     Document Type: Article

References (36)

1. Remuzzi, G., Perico, N., Macia, M. and Ruggenenti, P. (2005) The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int. 68, S57-S65.
2. Ruster, C. and Wolf, G. (2006) Renin-angiotensin-aldosterone system and progression of renal disease. J. Am. Soc. Nephrol. 17, 2985-2991.
3. Udani, S., Lazich, I. and Bakris, G. L. (2011) Epidemiology of hypertensive kidney disease. Nat. Rev. Nephrol. 7, 11-21.
4. Ruiz-Ortega, M., Ruperez, M., Esteban, V., Rodriguez-Vita, J., Sanchez-Lopez, E., Carvajal, G. and Egido, J. (2006) Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol. Dial. Transplant. 21, 16-20.
5. Mehta, P. K. and Griendling, K. K. (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell Physiol. 292, C82-C97.
6. Ruster, C. and Wolf, G. (2011) Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. J. Am. Soc. Nephrol. 22, 1189-1199.
7. Rodriguez-Vita, J., Sanchez-Lopez, E., Esteban, V., Ruperez, M., Egido, J. and Ruiz-Ortega, M. (2005) Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-β-independent mechanism. Circulation 111, 2509-2517.
8. Wang, W., Huang, X. R., Canlas, E., Oka, K., Truong, L. D., Deng, C., Bhowmick, N. A., Ju, W., Bottinger, E. P. and Lan, H. Y. (2006) Essential role of Smad3 in angiotensin II-induced vascular fibrosis. Circ. Res. 98, 1032-1039.
9. Carvajal, G., Rodriguez-Vita, J., Rodrigues-Diez, R., Sanchez-Lopez, E., Ruperez, M., Cartier, C., Esteban, V., Ortiz, A., Egido, J., Mezzano, S. A. and Ruiz-Ortega, M. (2008) Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation. Kidney Int. 74, 585-595.
10. Yang, F., Chung, A. C., Huang, X. R. and Lan, H. Y. (2009) Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-β-dependent and -independent Smad pathways: the role of Smad3. Hypertension 54, 877-884.
11. Yang, F., Huang, X. R., Chung, A. C., Hou, C. C., Lai, K. N. and Lan, H. Y. (2010) Essential role for Smad3 in angiotensin II-induced tubular epithelial-mesenchymal transition. J. Pathol. 221, 390-401.
12. Meng, X. M., Huang, X. R., Chung, A. C., Qin, W., Shao, X., Igarashi, P., Ju, W., Bottinger, E. P. and Lan, H. Y. (2010) Smad2 protects against TGFβ/Smad3-mediated renal fibrosis. J. Am. Soc. Nephrol. 21, 1477-1487.
13. Huang, X. R., Chung, A. C., Yang, F., Yue, W., Deng, C., Lau, C. P., Tse, H. F. and Lan, H. Y. (2010) Smad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling. Hypertension 55, 1165-1171.
14. Liu, Z., Huang, X. R. and Lan, H. Y. (2012) Smad3 mediates ANG II-induced hypertensive kidney disease in mice. Am. J. Physiol. Renal Physiol. 302, F986-F997.
15. Lan, H. Y. (2008) Smad7 as a therapeutic agent for chronic kidney diseases. Front. Biosci. 13, 4984-4992.
16. Chung, A. C., Huang, X. R., Zhou, L., Heuchel, R., Lai, K. N. and Lan, H. Y. (2009) Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice. Nephrol. Dial. Transplant. 24, 1443-1454.
17. Chen, H. Y., Huang, X. R., Wang, W., Li, J. H., Heuchel, R. L., Chung, A. C. and Lan, H. Y. (2011) The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential. Diabetes 60, 590-601.
18. Liu, G. X., Li, Y. Q., Huang, X. R., Wei, L., Chen, H. Y., Shi, Y. J., Heuchel, R. L. and Lan, H. Y. (2013) Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGFβ/Smad3-NF-κB-dependent mechanisms in mice. PLoS ONE 8, e53573.
19. Lan, H. Y., Mu, W., Tomita, N., Huang, X. R., Li, J. H., Zhu, H. J., Morishita, R. and Johnson, R. J. (2003) Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J. Am. Soc. Nephrol. 14, 1535-1548.
20. Lan, H. Y., Mu, W., Nikolic-Paterson, D. J. and Atkins, R. C. (1995) A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J. Histochem. Cytochem. 43, 97-102.
21. Qin, W., Chung, A. C., Huang, X. R., Meng, X. M., Hui, D. S., Yu, C. M., Sung, J. J. and Lan, H. Y. (2011) TGFβ/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J. Am. Soc. Nephrol. 22, 1462-1474.
22. Xiao, J., Meng, X. M., Huang, X. R., Chung, A. C., Feng, Y. L., Hui, D. S., Yu, C. M., Sung, J. J. and Lan, H. Y. (2012) miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol. Ther. 20, 1251-1260.
23. Hirano, F., Tanaka, H., Hirano, Y., Hiramoto, M., Handa, H., Makino, I. and Scheidereit, C. (1998) Functional interference of Sp1 and NF-κB through the same DNA binding site. Mol. Cell. Biol. 18, 1266-1274.
24. Zhang, W., Ou, J., Inagaki, Y., Greenwel, P. and Ramirez, F. (2000) Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor β1 stimulation of α2(I)-collagen (COL1A2) transcription. J. Biol. Chem. 275, 39237-39245.
25. Motojima, M., Ando, T. and Yoshioka, T. (2000) Sp1-like activity mediates angiotensin-II-induced plasminogen-activator inhibitor type-1 (PAI-1) gene expression in mesangial cells. Biochem. J. 349, 435-441.
26. Poncelet, A. C. and Schnaper, H. W. (2001) Sp1 and Smad proteins cooperate to mediate transforming growth factor-β1-induced α2(I)-collagen expression in human glomerular mesangial cells. J. Biol. Chem. 276, 6983-6992.
27. Wang, H., Garzon, R., Sun, H., Ladner, K. J., Singh, R., Dahlman, J., Cheng, A., Hall, B. M., Qualman, S. J., Chandler, D. S. et al. (2008) NF-κB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 14, 369-381.
28. Kavsak, P., Rasmussen, R. K., Causing, C. G., Bonni, S., Zhu, H., Thomsen, G. H. and Wrana, J. L. (2000) Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation. Mol. Cell 6, 1365-1375.
29. Tan, R., He, W., Lin, X., Kiss, L. P. and Liu, Y. (2008) Smad ubiquitination regulatory factor-2 in the fibrotic kidney: regulation, target specificity, and functional implication. Am. J. Physiol. Renal Physiol. 294, F1076-F1083.
30. Fukasawa, H., Yamamoto, T., Togawa, A., Ohashi, N., Fujigaki, Y., Oda, T., Uchida, C., Kitagawa, K., Hattori, T., Suzuki, S. et al. (2004) Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc. Natl. Acad. Sci. U.S.A. 101, 8687-8692.
31. Wang, W., Huang, X. R., Li, A. G., Liu, F., Li, J. H., Truong, L. D., Wang, X. J. and Lan, H. Y. (2005) Signaling mechanism of TGFβ1 in prevention of renal inflammation: role of Smad7. J. Am. Soc. Nephrol. 16, 1371-1383.
32. Ng, Y. Y., Hou, C. C., Wang, W., Huang, X. R. and Lan, H. Y. (2005) Blockade of NFκB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney. Kidney Int. 67, S83-S91.
33. Ka, S. M., Huang, X. R., Lan, H. Y., Tsai, P. Y., Yang, S. M., Shui, H. A. and Chen, A. (2007) Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice. J. Am. Soc. Nephrol. 18, 1777-1788.
34. Liu, S., Wu, L. C., Pang, J., Santhanam, R., Schwind, S., Wu, Y. Z., Hickey, C. J., Yu, J., Becker, H., Maharry, K. et al. (2010) Sp1/NFκB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. Cancer Cell 17, 333-347.
35. Chung, A. C., Dong, Y., Yang, W., Zhong, X., Li, R. and Lan, H. Y. (2013) Smad7 suppresses renal fibrosis via altering expression of TGFβ/Smad3-regulated microRNAs. Mol. Ther. 21, 388-398.
36. Wei, L. H., Huang, X. R., Zhang, Y., Li, Y. Q., Chen, H. Y., Yan, B. P., Yu, C. M. and Lan, H. Y. (2013) Smad7 inhibits angiotensin II-induced cardaic remodeling. Cardiovasc. Res. 99, 665-673.